Cargando…
Myc-Induced Liver Tumors in Transgenic Zebrafish Can Regress in tp53 Null Mutation
Hepatocellular carcinoma (HCC) is currently one of the top lethal cancers with an increasing trend. Deregulation of MYC in HCC is frequently detected and always correlated with poor prognosis. As the zebrafish genome contains two differentially expressed zebrafish myc orthologs, myca and mycb, it re...
Autores principales: | Sun, Lili, Nguyen, Anh Tuan, Spitsbergen, Jan M., Gong, Zhiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303426/ https://www.ncbi.nlm.nih.gov/pubmed/25612309 http://dx.doi.org/10.1371/journal.pone.0117249 |
Ejemplares similares
-
Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras(V12) expression in transgenic zebrafish
por: Nguyen, Anh Tuan, et al.
Publicado: (2016) -
An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening
por: Nguyen, Anh Tuan, et al.
Publicado: (2012) -
A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors
por: Li, Zhen, et al.
Publicado: (2013) -
Xmrk, Kras and Myc Transgenic Zebrafish Liver Cancer Models Share Molecular Signatures with Subsets of Human Hepatocellular Carcinoma
por: Zheng, Weiling, et al.
Publicado: (2014) -
A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish
por: Nguyen, Anh Tuan, et al.
Publicado: (2011)